Molecular marker for diagnosis and treatment of intrauterine fetal growth restriction

An endogenous and fetal technology, applied in the field of biomedicine, can solve the problems of decreased gene expression, increased methylation level, and increased risk of type 2 diabetes in IUGR patients

Active Publication Date: 2015-09-23
BEIJING FRIENDSHIP HOSPITAL CAPITAL MEDICAL UNIV
View PDF0 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Studies have reported that the methylation level of the pancreatic duodenum homeobox gene-1 (pancreatic duodenum homeobox gene-1, Pdx1) gene promoter re

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Molecular marker for diagnosis and treatment of intrauterine fetal growth restriction

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0035] Example 1 Screening of differentially methylated genes

[0036] 1. Sample collection: From January 1, 2013 to June 30, 2013, infants with intrauterine growth restriction (IUGR) hospitalized in the Department of Pediatrics of Beijing Friendship Hospital and infants appropriate for gestational age (appropriate for gestational age, AGA) clinical data and blood samples. Each patient signed an informed consent, and the study was approved by the Beijing Municipal Ethics Committee.

[0037] Clinical data: 8 cases of IUGR, 4 cases of AGA, there was no difference in gender between the two groups, gestational age and birth weight were expressed as median (minimum value, maximum value), and there was no special maternal pregnancy period. The control group were infants suitable for gestational age who were admitted to the hospital at the same time. They were mostly admitted to the hospital due to jaundice, neonatal wet lung and other problems, without other major diseases. Some in...

Embodiment 2

[0053] Example 2 Verification of Differentially Methylated Genes

[0054] In order to clarify whether the chip data is reliable, we collected 40 cases of IUGR children and 40 cases of AGA, and selected the differentially methylated gene PI3KR1, and used MassARRAY Compact System (purchased from Sequenom Company) for verification. The specific operation was in accordance with the instruction manual. conduct. In simple terms it looks like this:

[0055] 1. The extraction of gDNA was carried out according to the steps in Example 1.

[0056] 2. Sulfite modification was carried out according to the steps in Example 1.

[0057] 3. PCR amplifies the chr5:67585758-675867575' fragment, and the amplification primers are as follows:

[0058] 5' end primer:

[0059] aggaagagagTGTTTTTTTTAATGTGGTATATTTGTGA;

[0060] 3' end primer:

[0061] cagtaatacgactcactatagggagaaggctAAAAAATATCACCAAACCACTCCTAC.

[0062] 4. Use the Mass CLEAVE Kit kit for alkaline phosphatase treatment, and then use...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The present invention discloses application of a hypomethylation gene PIK3R1. On the one hand, the hypomethylation gene PIK3R1 can be used to the preparation of diagnostic products for intrauterine fetal growth restriction, and on the other hand the hypomethylation gene PIK3R1 can be used to prepare the medicament for treating intrauterine fetal growth restriction. The experiments of the present invention demonstrate that the patients with intrauterine fetal growth restriction have PIK3R1 gene hypomethylation in blood; the findings provide strong for molecular biology basis for the diagnosis and treatment of patients with intrauterine fetal growth restriction, and have far-reaching clinical significance and generalization value.

Description

technical field [0001] The invention belongs to the field of biomedicine and relates to a molecular marker for the diagnosis and treatment of fetal intrauterine growth restriction, in particular to the application of PIK3R1 gene methylation and its detection reagent in the preparation of fetal intrauterine growth restriction diagnostic products and therapeutic drugs. Background technique [0002] Intrauterine growth restriction (IUGR), also known as intrauterine growth retardation (IUGR), refers to the birth weight below the 10th percentile or lower than the average fetal weight of the corresponding gestational age. It is one of the main perinatal complications, and the mortality rate of perinatal infants is 8 times that of normal infants. It is estimated that approximately 30 million IUGR newborns are born each year in developing countries. The sequelae of IUGR are mainly divided into short-term sequelae and long-term sequelae after birth. The short-term sequelae of IUGR a...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C12Q1/68A61K45/00A61P15/00A61P3/00
CPCA61K45/00C12Q1/6883C12Q2600/154
Inventor 丁瑛雪崔红
Owner BEIJING FRIENDSHIP HOSPITAL CAPITAL MEDICAL UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap